Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Impact in
- Genetics 2.5k
- Epidemiology 1.1k
Classified as
- Journal
- New England Journal of Medicine
In The Last Decade
doi.org/10.1056/nejmoa050516 →Countries where authors are citing Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
This map shows the geographic impact of Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis more than expected).
Fields of papers citing Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
This network shows the impact of Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis.
About Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
This paper, published in 2005, received 3.2k indexed citations . Written by Paul J. Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan David Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer and Gary R. Lichtenstein covering the research area of Genetics. It is primarily cited by scholars working on Genetics (2.5k citations), Epidemiology (1.1k citations), Immunology (478 citations), Surgery (421 citations) and Molecular Biology (157 citations). Published in New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1056/nejmoa050516.